Category: Drug industry

5 11/19/2015

Media ignore impact of unsafe medical devices — unless the company CEO is a celebrity billionaire like Elizabeth Holmes


Trans-Pacific trade pact’s pharma provisions lack media scrutiny

2 10/20/2015

How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging

2 10/14/2015

Sponsored content, new cholesterol drugs, and the political process

1 10/8/2015

Was Turing Pharmaceuticals’ 5000% price increase a tipping point?

1 9/2/2015

Bankrupted by cancer: Why “cost” is an important criterion in our review process

1 8/21/2015

Roundup of flibanserin – ‘female Viagra’ – approval news; ‘game changer’ to some, ‘monumental bamboozlement’ for others

4 8/19/2015

What if we had an election and counted only half the ballots? When you’re burying research you’re also likely burying patients

3 7/27/2015

Fred Hutch president predicts cancer cure in 10 years; critics have heard it all before


Taking stock of new Alzheimer’s drug coverage: A “landmark breakthrough” that offers no “clinically apparent benefit”